French Auto Components Stock News

Christian Dior SE's ( EPA:CDI ) recent earnings report didn't offer any surprises, with the shares unchanged over the...

Planisware SAS half year 2026 earnings snapshot Planisware SAS (ENXTPA:PLNW) has drawn investor attention after reporting half year 2026 results. The company posted revenue of €106.13 million and net income of €28.59 million, alongside earnings per share of €0.41. See our latest analysis for Planisware SAS. Planisware SAS shares last closed at €24.5, with a 1-day share price return of 1.03% and a 90-day share price return of 40.16%. The 1-year total shareholder return of 33.58% suggests...

The market has punished Etablissements Maurel & Prom in recent months, with the stock down about 18% over 90 days and sitting near €7.90 despite very strong trailing profitability. That mismatch is the story today. The latest half year confirms eye catching net margins and a low P/E multiple against European oil and gas peers, yet most of the earnings power sits in non cash items and analysts expect profits to decline over the next few years. Short term traders see a cheap stock. Long term...

AXA (ENXTPA:CS) has drawn fresh attention after reporting half year 2026 earnings on 31 July, with net income of €4,171 million and earnings per share of €2.01 from continuing operations. See our latest analysis for AXA. AXA’s half year 2026 results appear to have supported a steady trend, with the 90 day share price return of 9.77% and 1 year total shareholder return of 15.36% both pointing to building momentum from a longer term base. If the AXA update has you thinking about where else...

Airbus (ENXTPA:AIR) has drawn fresh attention after reporting second quarter 2026 earnings, with sales of €20,525 million and net income of €1,657 million, alongside continued large commercial aircraft order activity. See our latest analysis for Airbus. Airbus shares trade at €212.45 after a small 1-day share price decline of 1.16%, while a 90-day share price return of 18.11% and a 1-year total shareholder return of 21.97% suggest momentum has been building alongside the recent earnings and...

BNP Paribas stock has almost tripled over the past five years, yet current checks suggest the shares now look roughly in line with an estimate of intrinsic value rather than clearly cheap or clearly expensive. BNP Paribas has returned 196.0% over 5 years, which puts extra focus on whether today’s price still leaves much room for error. Recent deals, including Arval’s acquisition of Athlon and BNP Paribas Cardif’s move to increase its stake in Indiafirst Life, can support expectations for non...

H&K (ENXTPA:MLHK) has moved back into focus after the company raised its full year 2026 earnings guidance, with management now expecting revenue and total operating performance to improve in a high double digit million range. See our latest analysis for H&K. The raised 2026 guidance appears to have coincided with a strong shift in sentiment, with H&K’s 1 month share price return of 25.45% and 7 day share price return of 9.38% contrasting with a year to date share price decline of 20.45% and a...

Why Orange stock is back in focus after earnings and data centre deal Orange (ENXTPA:ORA) has moved into the spotlight after half year 2026 results showed a swing from loss to profit, alongside a new data centre joint venture aimed at serving AI and cloud demand in France. See our latest analysis for Orange. Orange’s recent earnings swing and the planned data centre joint venture arrive after a mixed share price run, with short term momentum still patchy but longer term total shareholder...

In late July 2026, bioMérieux S.A. reported half-year results showing sales of €1,964.6 million versus €2,043.8 million a year earlier, while net income rose to €226.1 million from €161 million and basic earnings per share from continuing operations increased to €1.92 from €1.36. The combination of lower sales yet higher earnings suggests meaningful efficiency gains or cost discipline that materially improved profitability for the period. We’ll now examine how this profitability improvement,...

Central banks are easing away from aggressive tightening as inflation readings cool in several regions, which takes some pressure off funding costs for capital heavy sectors such as aerospace and defense. For investors, that creates a window where demand for security and critical infrastructure still matters, yet money is not getting steadily more expensive. This article highlights three Aerospace And Defense screener stocks that stand out on current fundamentals. The three aerospace and...

Air Liquide has released its half-year 2026 results, reporting modest year-on-year increases in sales to €13,827.9 million and net income to €1,822.6 million, alongside slightly higher earnings per share. The company also committed over US$150 million to a new ultra-pure industrial gas facility in Idaho to support advanced semiconductor memory production, underlining its deepening role in supplying critical materials for AI-related chip manufacturing and reshoring efforts in the U.S. We’ll...

Edenred (ENXTPA:EDEN) has drawn fresh attention after agreeing to bring Abry Partners into Edenred Pay North America through a €75 million equivalent cash investment and a structure that gives Abry exposure to future equity value. See our latest analysis for Edenred. The Edenred share price has climbed sharply in recent months, with a 30 day share price return of 22.46% and a 90 day gain of 36.51%. The year to date share price return of 53.85% contrasts with a weaker 3 year total shareholder...

Capgemini earnings update and why the stock is in focus Capgemini (ENXTPA:CAP) has drawn fresh attention after reporting half year 2026 results. Sales reached €12,082 million compared with €11,107 million a year earlier, while net income and earnings per share declined over the same period. See our latest analysis for Capgemini. The earnings release has arrived at a time when Capgemini’s share price has shown a 17.46% 1 month share price return, yet the stock remains down 22.56% on a year to...

Diageo’s new US$1b cost cutting plan and the share price surge that followed has put the entire global spirits sector under a sharper spotlight. When a heavyweight publicly chases efficiency, it can pressure competitors’ margins, pricing and brand spending. That can create both blind spots and opportunities for investors. This article examines how that news may affect three stocks closely exposed to the same forces, and why that may be relevant for your portfolio decisions now. Constellation...

The market for Bureau Veritas SA's ( EPA:BVI ) shares didn't move much after it posted weak earnings recently. We think...

TotalEnergies (ENXTPA:TTE) has returned to focus after it and partner Eni approved the Cronos gas field development in Cyprus, a new offshore LNG project that will supply Egyptian liquefaction facilities and European exports. See our latest analysis for TotalEnergies. At a latest share price of €73.80, TotalEnergies has pulled back slightly in the past week, with a 7 day share price return of a 2.68% decline, after a strong 30 day share price return of 9.90% and a year to date share price...

Veolia Environnement (ENXTPA:VIE) is in focus after securing a long term water and sanitation contract in Cúcuta, Colombia, alongside reporting half year 2026 results and reaffirming its 2026 dividend guidance. See our latest analysis for Veolia Environnement. At a share price of €34.98, Veolia Environnement has delivered a 16.06% year to date share price return, supported by the Cúcuta contract, half year 2026 earnings and reaffirmed 2026 dividend guidance. Its 1 year total shareholder...

In late July 2026, the European Commission approved Sanofi’s MenQuadfi meningococcal vaccine for use in EU infants from six weeks of age, extending coverage against serogroups A, C, W, and Y and aligning dosing with routine pediatric schedules. This broadened indication gives Sanofi an earlier entry point into infant immunization programs, potentially deepening its vaccines footprint in a high‑need, high‑risk population. Next, we’ll examine how gaining infant approval for MenQuadfi across...

Vinci SA recently reported past half-year 2026 results showing sales of €36,040 million and net income of €2,078 million, alongside higher earnings per share versus a year earlier. The company also approved a higher interim dividend of €1.10 per share for 2026 and confirmed guidance for further growth in revenue, operating earnings and net income, underlining management’s confidence in its current trajectory. Next, we’ll examine how Vinci’s stronger first-half profitability and increased...

In recent weeks, the European markets have shown resilience, with the pan-European STOXX Europe 600 Index reaching new highs driven by strong corporate earnings and a recovery in sentiment toward AI-related stocks. As investors navigate these evolving conditions, identifying potentially undervalued stocks can be a strategic approach to capitalize on market opportunities.

The investors in Worldline SA 's ( EPA:WLN ) will be rubbing their hands together with glee today, after the share...

Why Safran stock is in focus after new guidance and half year results Safran (ENXTPA:SAF) drew fresh attention after its board met on 27 July to review half year 2026 figures and the company raised full year revenue growth guidance despite a drop in net income. The company now expects 2026 revenue growth in the mid teens, with management indicating a target above €36b. This update followed half year 2026 sales of €17,245m and revenue of €17,458m. See our latest analysis for Safran. Safran’s...

Eurazeo stock barely flinched into these H1 2026 results, with the shares at €50.65 after a solid run over the past month. Yet the earnings story is less about the share price and more about the balance sheet. The group still sits on a rich price to sales multiple of 9.3x while reporting losses on a trailing twelve month basis. The real headline is the tension between a high valuation, ongoing losses and a 6.34% dividend yield that is poorly covered by earnings and free cash flow. Like the...

The market has spent the past three months marking Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée down, with the stock now about 12% lower even after closing at €138. Yet the latest half year numbers tell a more complicated story. Earnings over the last 12 months reached €105.3 million and the net profit margin sits at 23.1%. The stock trades on a P/E of 9.7x, which leaves you weighing a cheaper valuation against a bank that still carries 65% of its liabilities in higher risk...